paclitaxel has been researched along with Microsatellite Instability in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 4 (66.67) | 2.80 |
Authors | Studies |
---|---|
Demes, M; Eichler, K; Jeroch, J; Martin, D; Pession, U; Schulze, F; Waidmann, O; Wild, P | 1 |
Auranen, A; Black, D; Boere, I; Buscema, J; Chase, DM; Cibula, D; Coleman, RL; Copeland, LJ; dePont Christensen, R; Gilbert, L; Gill, SE; Gold, MA; Hanker, LC; He, Z; Herzog, TJ; Landrum, LM; McCourt, C; Mirza, MR; Monk, BJ; Novák, Z; Pothuri, B; Powell, MA; Raspagliesi, F; Shahin, MS; Sharma, S; Slomovitz, BM; Stevens, S; Stuckey, A; Tian, M; Valabrega, G; Zografos, E | 1 |
Mano, M; Masuda, N; Masuyama, M; Mizutani, M; Mori, K; Morikawa, N; Otani, Y; Yasojima, H | 1 |
Ackroyd, SA; Huang, ES; Kurnit, KC; Lee, NK | 1 |
Berlin, J; Cardin, D; Das, S | 1 |
Ishibashi, T; Ishikawa, M; Ishikawa, N; Kurioka, H; Kyo, S; Minamoto, T; Nakamura, K; Nakayama, K; Nakayama, S; Ono, R; Onuma, H; Otsuki, Y; Razia, S; Yamashita, H | 1 |
1 review(s) available for paclitaxel and Microsatellite Instability
Article | Year |
---|---|
Harnessing the Immune System in Pancreatic Cancer.
Topics: Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Immunotherapy; Irinotecan; Leucovorin; Microsatellite Instability; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms | 2018 |
1 trial(s) available for paclitaxel and Microsatellite Instability
Article | Year |
---|---|
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; DNA Mismatch Repair; Double-Blind Method; Endometrial Neoplasms; Female; Humans; Immune Checkpoint Inhibitors; Microsatellite Instability; Neoplasm Recurrence, Local; Paclitaxel | 2023 |
4 other study(ies) available for paclitaxel and Microsatellite Instability
Article | Year |
---|---|
Site of analysis matters - Ongoing complete response to Nivolumab in a patient with HIV/HPV related metastatic anal cancer and
Topics: Anus Neoplasms; Carboplatin; HIV Infections; Humans; Microsatellite Instability; Mutation; MutL Protein Homolog 1; Nivolumab; Paclitaxel; Papillomavirus Infections; Programmed Cell Death 1 Receptor | 2022 |
Rechallenge of anti-PD-1/PD-L1 antibody showed a good response to metastatic breast cancer: a case report.
Topics: Albumins; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Drug Resistance, Neoplasm; Female; Humans; Immune Checkpoint Inhibitors; Lung Neoplasms; Microsatellite Instability; Middle Aged; Paclitaxel; Retreatment; Treatment Outcome; Triple Negative Breast Neoplasms | 2021 |
Pembrolizumab and lenvatinib versus carboplatin and paclitaxel as first-line therapy for advanced or recurrent endometrial cancer: A Markov analysis.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cost-Benefit Analysis; Decision Trees; Drug Costs; Endometrial Neoplasms; Female; Humans; Markov Chains; Microsatellite Instability; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Phenylurea Compounds; Progression-Free Survival; Quality of Life; Quality-Adjusted Life Years; Quinolines | 2021 |
Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies).
Topics: Aged; Antibodies, Neutralizing; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carboplatin; Carcinoma; Carcinoma, Endometrioid; Cisplatin; DNA Mismatch Repair; Doxorubicin; Endometrial Neoplasms; Female; Gene Expression; Humans; Immunophenotyping; Lymphocytes, Tumor-Infiltrating; Microsatellite Instability; Middle Aged; Neoplasm Staging; Paclitaxel; Prognosis; Programmed Cell Death 1 Receptor | 2019 |